MSOS Discussion Board

Magnesium Sulfate 50% for Eclamptic Seizures

Stephen Rolfe's picture

Forums: 

Good morning!

Our L&D group recently requested that we stock 10 or 20 mL vials of magnesium sulfate 50% on override in their ADC for the treatment of eclamptic seizures. This would be used for IM injection (5 gm in each buttock) if the patient does not have IV access. A few questions for the group:

1. Do you stock magnesium sulfate 50% vials in an ADC for the treatment eclamptic seizures? If yes, what vial size?

2. Do you have this medication on override?

Hazardous IV Compounding

Heather Queen's picture

Forums: 

I am working on cleaning up our processes for our new IV cleanrooms. Could someone tell me what your processes are for the NIOSH group 2 and 3 rated hazardous drugs? Do you use the Hazardous cleanroom to compound this group of medications? Specifically phenytoin, fosphenytoin and ganciclovir(group 2) and pamidronate, oxytocin, valproate, voriconazole, zometa(group 3 reproductive risk only).

Open position in med safety at AHRQ

Mike Cohen's picture

Forums: 

Sorry, the links didn't go through... let's try again:

Colleagues: There is an open position at AHRQ in their Patient Safety Program.

They’ve asked me to post the following:

The Agency for Healthcare Research and Quality’s (AHRQ) Division of General Patient Safety has an exciting opportunity to serve as a Health Scientist Administrator. AHRQ is seeking candidates from the general public or Federal workforce who will be responsible for supporting a portfolio of research to improve the safe use of medications. Deadline for applications is March 22, 2021.

Open position in med safety at AHRQ

Mike Cohen's picture

Forums: 

Colleagues: There is an open position at AHRQ in their Patient Safety Program.

They’ve asked me to post the following:

The Agency for Healthcare Research and Quality’s (AHRQ) Division of General Patient Safety has an exciting opportunity to serve as a Health Scientist Administrator. AHRQ is seeking candidates from the general public or Federal workforce who will be responsible for supporting a portfolio of research to improve the safe use of medications. Deadline for applications is March 22, 2021.

Request #: 339634

HRSA B/O: AHRQ / CQUIPS

Change to TPN check process with EHR-ExactaMix interoperability?

Karen Thompson's picture

Forums: 

We will soon have a direct connection between our EHR (Epic) and our ExactaMix TPN compounder. This eliminates having to transcribe TPN orders into Abacus, which is a big step to reduce errors and improve efficiency! I am now rethinking all of the double checks we have done historically with TPNs, and wondering if they are still necessary. Obviously, there is no longer a need for a 2nd RPh to check the transcription step since it doesn't exist. I am now wondering if there is still a need for 2 RNs to confirm the amounts of each ingredient in the TPN label.

BCMA and Max Cumulative Dosing for PRN Medications

Jennifer Matias's picture

Forums: 

Hi All,

For those who have BCMA systems that track max cumulative dosing for PRN meds, what medications do you include?

Examples:
- acetaminophen PRN - alerting the nurse if dose about to be administered exceeds 4,000 mg/ 24 hours
- sumatriptan oral PRN - alerting the nurse if dose about to be administered exceeds 200 mg/ 24 hours

Also interested in any thoughts in general on the subject i.e. barriers to implementation or why your organization decided not to pursue this.

Thank you!

Pages

Subscribe to RSS - MSOS Discussion Board